Is the SpaceX IPO Overpriced? Here's How Much It Could Be Worth, According to a Valuation Expert.

SpaceX is targeting a potential IPO valuation of $1.75 trillion or more, but valuation expert Aswath Damodaran estimates fair value at about $1.22 trillion based on $320 billion of future revenue and a blended operating margin near 50%. The article highlights strong competitive advantages in launch and satellite internet, but also notes uncertainty around the AI business, IPO supply constraints, and possible lockup-period selling pressure. SpaceX reportedly generated $15.6 billion in revenue last year, implying a rich 112x sales multiple at the proposed valuation.

Analysis

The market is likely underappreciating the sequencing risk in a SpaceX listing: the IPO is not a clean growth monetization event, it is a liquidity event into a structurally constrained float. With only a sliver of shares tradable initially, the first-order tape could be supportive, but the more important second-order effect is post-lockup supply from early holders who have embedded decades of unrealized gains and will likely use the public market as a de-risking outlet. That creates a classic “good business, bad float” setup where price can gap above fundamentals early and then normalize once real supply appears.

From a competitive standpoint, the moat is strongest where SpaceX controls both the launch layer and the downstream payload economics. That means Amazon and Alphabet may remain strategically compelled customers before they become real rivals, which ironically strengthens SpaceX’s pricing power in launch while delaying any credible share loss in satellite internet. The hidden implication is that the best public-market beneficiaries may be the launch-adjacent supply chain and enablers, not the direct competitor names: firms with propulsion, avionics, RF, and ground-segment exposure can ride rising capex without taking single-company execution risk.

The biggest downside risk is not that the core launch franchise fails; it is that capital allocation into adjacent moonshots dilutes returns and stretches management bandwidth. A public listing also changes the signaling game: once SpaceX is marked daily, the market will penalize long-duration initiatives with no clear monetization path faster than private investors would, compressing the valuation premium if growth milestones slip even modestly. On timing, the next 3-6 months are about IPO scarcity and momentum; the next 12-24 months are about whether Starlink economics and launch cadence can justify a trillion-plus multiple before lockup supply hits.

The contrarian miss is that consensus is treating the valuation debate as a binary overpay/underpay call, when the more actionable edge is path dependency. If the first filing reveals heavier reliance on a few customers, higher launch concentration, or slower conversion of satellite capex into cash flow, the stock could re-rate quickly even if headline revenue growth remains strong. Conversely, if IPO demand is driven by scarcity rather than fundamentals, a weak aftermarket does not invalidate the franchise — it simply creates a much better entry point once insider selling begins.

Key Decisions for Investors

• Do not chase the IPO on day one; wait for the lockup calendar and look to buy any 15-25% post-listing drawdown created by insider supply over the following 3-9 months.
• Express the SpaceX ecosystem theme via a basket long in AMZN/GOOGL launch-adjacent suppliers only if the IPO proves durable; otherwise fade the names on any launch-cost margin compression from carrier competition.
• Overweight NVDA on a 6-12 month horizon as the cleaner AI infrastructure beneficiary versus speculative private-model exposure; SpaceX’s AI optionality is unlikely to cash-flow into public valuation quickly.
• If listed options become liquid, consider a bearish call spread or put spread on SpaceX into the first post-IPO earnings cycle, targeting a valuation reset if growth guidance is not explicit.
• Relative-value trade: long high-quality aerospace/space supply-chain names, short direct IPO enthusiasm via an index or growth proxy, because public-market scarcity can inflate the headline while fundamentals accrue elsewhere.